相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
Qingqing Cheng et al.
FRONTIERS IN ONCOLOGY (2020)
Comparison of Model-Free and Model-Based Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Parameters for Predicting Breast Cancers' Response to Neoadjuvant Chemotherapy
Guangjie Lv et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2020)
Diffusion-Weighted Magnetic Resonance Imaging of Patients with Breast Cancer Following Neoadjuvant Chemotherapy Provides Early Prediction of Pathological Response - A Prospective Study
Nara P. Pereira et al.
SCIENTIFIC REPORTS (2019)
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)
Simon Peter Gampenrieder et al.
BREAST CANCER RESEARCH (2019)
Apparent Diffusion Coefficient Value to Evaluate Tumor Response After Neoadjuvant Chemotherapy in Patients with Breast Cancer
Yazmin Aseret Ramirez-Galvan et al.
ACADEMIC RADIOLOGY (2018)
Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer
Yunju Kim et al.
KOREAN JOURNAL OF RADIOLOGY (2018)
Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer
Yunju Kim et al.
MAGNETIC RESONANCE IMAGING (2018)
Can Multi-Parametric MR Based Approach Improve the Predictive Value of Pathological and Clinical Therapeutic Response in Breast Cancer Patients?
Uma Sharma et al.
FRONTIERS IN ONCOLOGY (2018)
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis
John Virostko et al.
JOURNAL OF MEDICAL IMAGING (2018)
Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations
Reem Bedair et al.
EUROPEAN RADIOLOGY (2017)
Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients
Ming Fan et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Pre-operative assessment of residual disease in locally advanced breast cancer patients: A sequential study by quantitative diffusion weighted MRI as a function of therapy
Khushbu Agarwal et al.
MAGNETIC RESONANCE IMAGING (2017)
Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
Chao You et al.
TRANSLATIONAL ONCOLOGY (2017)
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Inflammatory Breast Cancer Prior to and After Neoadjuvant Treatment
Dominique J. P. van Uden et al.
BREAST CARE (2017)
Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging
Valentina Iotti et al.
BREAST CANCER RESEARCH (2017)
Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis
Yan-Lin Gu et al.
CLINICAL BREAST CANCER (2017)
Multi-parametric MRI in the early prediction of response to neo-adjuvant chemotherapy in breast cancer: Value of non-modelled parameters
Elizabeth A. M. O'Flynn et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Shunan Che et al.
MEDICINE (2016)
Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI
Alina Tudorica et al.
TRANSLATIONAL ONCOLOGY (2016)
Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
Takayo Fukuda et al.
SPRINGERPLUS (2016)
Role of MRI diffusion as an adjunct to contrast enhanced MRI of the breast for the evaluation of breast cancer patients receiving neoadjuvent chemotherapy
Hebatalla El Kassas et al.
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2016)
Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT
Yeong Yi An et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer
Xia Li et al.
INVESTIGATIVE RADIOLOGY (2014)
Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy
Soo Yeon Hahn et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment
Enida Bufi et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
DCE-MRI Analysis Methods for Predicting the Response of Breast Cancer to Neoadjuvant Chemotherapy: Pilot Study Findings
Xia Li et al.
MAGNETIC RESONANCE IN MEDICINE (2014)
Changes in Primary Breast Cancer Heterogeneity May Augment Midtreatment MR Imaging Assessment of Response to Neoadjuvant Chemotherapy
Jyoti Parikh et al.
RADIOLOGY (2014)
Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
Lian-Ming Wu et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Dynamic Breast Magnetic Resonance Imaging: Pretreatment Prediction of Tumor Response to Neoadjuvant Chemotherapy
He Dongfeng et al.
CLINICAL BREAST CANCER (2012)
Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer
Sang Hee Park et al.
EUROPEAN RADIOLOGY (2012)
Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS
Hee Jung Shin et al.
NMR IN BIOMEDICINE (2012)
Neoadjuvant Chemotherapy in Breast Cancer: Prediction of Pathologic Response with PET/CT and Dynamic Contrast-enhanced MR Imaging-Prospective Assessment
Ukihide Tateishi et al.
RADIOLOGY (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Diffusion-weighted Imaging in Evaluating the Response to Neoadjuvant Breast Cancer Treatment
Paolo Belli et al.
BREAST JOURNAL (2011)
Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
A. Fangberget et al.
EUROPEAN RADIOLOGY (2011)
Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion-weighted Imaging-Comparison with Contrast-enhanced MR Imaging and Pathologic Findings
Reiko Woodhams et al.
RADIOLOGY (2010)
Dynamic Contrast-Enhanced MRI for Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: Initial Results
Claudette E. Loo et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
Mei-Lin W. Ah-See et al.
CLINICAL CANCER RESEARCH (2008)
Magnetic resonance imaging in the breast cancer patient: Curb your enthusiasm
Monica Morrow
JOURNAL OF CLINICAL ONCOLOGY (2008)
Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer
Aoi Matsuoka et al.
RADIATION MEDICINE (2008)
Meta-analysis of MR imaging in the diagnosis of breast lesions
Nicky H. G. M. Peters et al.
RADIOLOGY (2008)
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update
M Kaufmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer:: The GEPARDUO Study of the German Breast Group
G von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy
V Londero et al.
EUROPEAN RADIOLOGY (2004)